base-metals-investing Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
base-metals-investing First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
base-metals-investing Real-World Evidence Studies of XPHOZAH® Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
base-metals-investing Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
base-metals-investing Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
base-metals-investing Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® at the American College of Gastroenterology's 2025 Annual Meeting
base-metals-investing Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week
base-metals-investing Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
Terra Clean adds 3,395 acres of Uranium Claims in Wyoming adding Highly Prospective Uranium Properties to its Growing Uranium Portfolio
Terra Clean adds 3,395 acres of Uranium Claims in Wyoming adding Highly Prospective Uranium Properties to its Growing Uranium Portfolio
Terra Clean adds 3,395 acres of Uranium Claims in Wyoming adding Highly Prospective Uranium Properties to its Growing Uranium Portfolio
